Notably, high CD40 is associated with better overall survival (OS) in two melanoma cohorts of patients treated with α-CTLA4 (n = 15, p = 0.0067) or α-PD1 (n = 47, p = 0.0381). The gene discussed is CD40; the disease is melanoma.